Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Science & Medicine: San Antonio's fungus lab is on the front line of a growing drug-resistance crisis

16 August 2026 · By · Wire by Fusion42

Published

16 August 2026

Topic

opportunities

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at tpr.org →

◆ Verified

Fusion42 · 16 August 2026 · Fusion42 review

San Antonio's Fungus Testing Laboratory identifies new fungal species and monitors drug resistance trends, playing a crucial role in combating antifungal resistance and aiding new drug development in North America.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ ◆ The Wire takeaway

You cannot afford to overlook fungal drug resistance in your healthtech strategy; opportunities arise to partner early with labs like UT Health San Antonio for cutting-edge antifungal developments.

◆ Coverage

1 source · 16 Aug 2026

◆ Related on Wire

◆ Topics

Biotechfungal-pathogensdrug-resistancebiotechhealthcareantifungal-drugs